Published 2000
| Version v1.0.0
Journal Article
Open
Sumatriptan Nasal Spray for Acute Migraine
Creators
Abstract
A multicenter, randomized, double-blind, placebo-controlled trial of sumatriptan nasal spray (5 mg, 10 mg, and 20 mg) was conducted in 653 adolescents presenting with acute migraine at the Palm Beach Headache Center, Florida; Cleveland Clinic, OH; Michigan Headache Institute, Ann Arbor; and San Antonio Center, TX.Files
PNB-14-82-b.pdf
Files
(2.8 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:5e4592744550c6989a97ee4cea753ec8
|
2.8 MB | Preview Download |
Additional details
Identifiers
- Other
- PNB-14-82-b
Dates
- Created
-
2000When the item was originally created.